Niki BiosolutionsNIKI
13F holders, Q2 2024 (June 30)4holders −1
2new positions
3sold out
1famous investor
$4.40avg. 13F price*
At the end of Q2 2024, 4 institutions reported holding Niki Biosolutions Inc. (NIKI) in their 13F filings, down 1 from Q1 2024. 2 opened new positions and 3 sold out. The largest holders were Geode Capital Management, LLC ($175K), Citadel Advisors ($75K) and Morgan Stanley ($50K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Niki Biosolutions Inc.
- Filed as
- APTORUM GROUP LIMITED (Q2 2024)
- CUSIP
- G6096M122
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $107K |
| Exits | 3 | $148K |
All 13F filers, Q1 2024 → Q2 2024: 33,090 shares bought and 15,561 shares sold, net +17,529 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Geode Capital Management, LLC | 0.00% | Add +1.1% | 39,852 | $175K |
| Citadel Advisors | 0.00% | New | 17,023 | $75K |
| Morgan Stanley | 0.00% | Add +249.8% | 11,510 | $50K |
| UBS Group AG | 0.00% | New | 7,422 | $33K |
"% of holder's portfolio" is NIKI's weight in each manager's 13F, not the share of Niki Biosolutions Inc. the manager owns.